A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Global Pharmacy Automation in Oncology Drugs Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2020 to 2028.
Global Pharmacy Automation in Oncology Drugs Market Analysis
According to COGNIZANCE MARKET RESEARCH, the Pharmacy Automation in Oncology Drugs market is expected to register a CAGR of 4.8% from 2016 to 2026.
What is Pharmacy Automation in Oncology Drugs?
Pharmacy automation comprises the mechanical systems of drug handling as well as distribution. Many pharmacy activities may be required, including the measuring of small objects; the measurement and combining of compounding powders and liquids; the monitoring and upgrading of computer consumer data; and inventory control. Some of the major benefits include lowered cost-per-dose of medication, reduced pharmacy and medication waste, reduced need for medication outsourcing, enhanced patient safety, and others.
Global Pharmacy Automation in Oncology Drugs Market Outlook
The demand for pharmacy automation systems is driven by an increased need to reduce medication mistakes, the benefits of the market for pharmacy automation systems over manual medication dispensing, and the advancement of enhanced features. Furthermore, healthcare technology developments in developing nations are projected to generate new prospects for business expansion. Strong investment in capital and tight government regulations are major hurdles that hinder the development of the sector.
The expansion of the industry would impact the increase of cancer patients. Cancer is a broad community of diseases that as irregular cells develop uncontrollably, may originate in almost any organ or tissue of the body, go beyond their natural limits to invade adjoining areas of the body, and/or spread to other organs. The latter approach is called metastasizing and is a significant cause of cancer mortality. Some common names for cancer include neoplasm and malignant tumors. For instance, according to the World Health Organization, Cancer is the world’s second leading cause of death, responsible for an estimated 9.6 million casualties in 2018, or one in six deaths. The most prevalent forms of cancer in men are kidney, prostate, colorectal, stomach and liver cancer, while breast, colorectal, lung, cervical and thyroid cancer are the most common in women.
The report offers the revenue of the global pharmacy automation in oncology drugs market for the period 2018–2028, considering 2018 as a historical year, 2019 as the base year, and 2020 to 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global pharmacy automation in the oncology drugs market for the forecast period. The pharmacy automation in oncology drugs market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global pharmacy automation in oncology drugs market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global Pharmacy Automation in Oncology Drugs market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the global Pharmacy Automation in Oncology Drugs market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the global Pharmacy Automation in Oncology Drugs market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the global pharmacy automation in oncology drugs market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the global Pharmacy Automation in Oncology Drugs market. The subsequent section of the global Pharmacy Automation in Oncology Drugs report highlights the USPs, which include key industry events (product launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Global Pharmacy Automation in Oncology Drugs Market Competitive Landscape
The “Global Pharmacy Automation in Oncology Drugs Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Talyst, LLC., ARxIUM, OMNICELL, INC., Cerner Corporation, Capsa Healthcare, Parata Systems, LLC, ScriptPro LLC, RxSafe, LLC., RxMedic Systems, Inc., MedAvail Technologies, Inc., Asteres Inc., PerceptiMed, Inc., BD, Baxter, Fullscript, McKesson Corporation, Innovation Associates, and others.
The report explores the competitive scenario of the global Pharmacy Automation in Oncology Drugs market. Major players operating in the global Pharmacy Automation in Oncology Drugs market have been identified and profiled for unique commercial attributes. Company overview (company description, product portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the global PHARMACY AUTOMATION IN ONCOLOGY DRUGS market report.
Key Questions Answered in Pharmacy Automation In Oncology Drugs Market Report
- What are the major players operating in the global market?
- What are trends, drivers, opportunities, and challenges in the global market?
- Which is the leading country in the global market?
- What are the revenue share forecasts of key sections of the global pharmacy automation in oncology drugs during the estimated timeframe?
- Which segment is expected to lead the global market in terms of revenue by 2028?
- How partnerships & alliances among companies operating in the market are broadening the scope of the global market?
- Who are the top 7 leaders of the global market?
- Which unmet needs will remain unaddressed over the projected period?
The global Pharmacy Automation in Oncology Drugs market has been segmented as below:
Global Market, By Pharmacy Type
- Chain and Federal Contraceptive Pills
Global Market, By Pharmacy Size
- Large Size Pharmacy
- Medium Size Pharmacy
- Small Size Pharmacy
Global Market, By Application
- Drug Dispensing and Packaging
- Drug Storage and Inventory Management
Global Market, By End User
- Inpatient Pharmacies
- Outpatient Pharmacies
- Retail Pharmacies,
- Online Pharmacies
- Central Fill/Mail Order Pharmacies
- Pharmacy Benefit Management Organizations
Global Market, By Distribution Channel
- Direct Tender
- Third-Party Distributor
Global Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of the Middle East & Africa